GREY:DGCRF - Post by User
Comment by
ready2go1on Mar 22, 2010 4:49pm
289 Views
Post# 16910895
RE: PCA3 ON Panther?
RE: PCA3 ON Panther?I have had the chance over the past 2-3 yrs to speak with one of the analysts that covers GPRO. His optimistic opinion on PCA3 and how it will impact Gen-Probe has always given me comfort during down periods for CUR. He was always someone that was pushing GPRO to move forward and get aggressive bringing pca3 to the market. I have mentioned before that he does not follow CUR but does say that PCA3 will be a winner and he can only imagine the impact it will have on CUR's share price.
We are getting close and I would expect some type of release when they complete the FDA trial in April. I would expect a 30-50% share price move. Between now and than I would like to see us stabilize and make the run to $2.00 just prior to the news.
I read the last poster hoping for a fast track; all I can say to that ,is that the GSK trial was very similar to the current FDA trial Gen-Probe is currently running, so with the 30 published trials, the 4+ year GSK trial and the GPRO's trial, I would look for a quick response from the FDA. PCA3 is coming on at the right time, expect big #'s out of the gate.
(by the way, it looks as if we can clear out the sell order sitting on some brokers desk with one run.)